A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer

Charalampos S. Floudas, Gagandeep Brar, Donna Mabry-Hrones, Austin G. Duffy, Bradford Wood, Elliot Levy, Venkatesh Krishnasamy, Suzanne Fioravanti, Cecilia M. Bonilla, Melissa Walker, Maria Pia Morelli, David E. Kleiner, Seth M. Steinberg, William D. Figg, Tim F. Greten, Changqing Xie^*

^*Corresponding author for this work